Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other Non-Current Liabilities (2018 - 2025)

Regenxbio has reported Other Non-Current Liabilities over the past 8 years, most recently at $638000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $638000.0 for Q4 2025, down 82.45% from a year ago — trailing twelve months through Dec 2025 was $638000.0 (down 82.45% YoY), and the annual figure for FY2025 was $638000.0, down 82.45%.
  • Other Non-Current Liabilities for Q4 2025 was $638000.0 at Regenxbio, down from $648000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for RGNX hit a ceiling of $171.3 million in Q4 2021 and a floor of $448000.0 in Q1 2021.
  • Median Other Non-Current Liabilities over the past 5 years was $21.8 million (2022), compared with a mean of $47.4 million.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 27246.88% in 2022 and later crashed 98.48% in 2025.
  • Regenxbio's Other Non-Current Liabilities stood at $171.3 million in 2021, then decreased by 19.69% to $137.6 million in 2022, then crashed by 68.4% to $43.5 million in 2023, then tumbled by 91.64% to $3.6 million in 2024, then crashed by 82.45% to $638000.0 in 2025.
  • The last three reported values for Other Non-Current Liabilities were $638000.0 (Q4 2025), $648000.0 (Q3 2025), and $664000.0 (Q2 2025) per Business Quant data.